Related Experiment Videos
Paraneoplastic retinopathy associated with uterine sarcoma
G H Eltabbakh1, D L Hoogerland, M C Kay
1Department of Gynecology, University of Wisconsin Medical School, Milwaukee 53201, USA.
Gynecologic Oncology
|July 1, 1995
Summary
This case study reports the first instance of cancer-associated retinopathy (CAR) linked to uterine sarcoma. Treatment of the uterine sarcoma led to improved vision and stabilized visual fields in the patient.
Area of Science:
- Ophthalmology
- Gynecologic Oncology
- Onconeurology
Background:
- Cancer-associated retinopathy (CAR) is a rare autoimmune disorder characterized by the presence of antiretinal antibodies.
- Paraneoplastic syndromes can manifest with various ocular and neurological symptoms, often preceding cancer diagnosis.
- Uterine sarcoma is an uncommon malignancy arising from the connective tissue of the uterus.
Observation:
- A 65-year-old woman presented with sudden vision loss, photophobia, and restricted visual fields.
- Elevated antiretinal antibodies confirmed the diagnosis of cancer-associated retinopathy.
- A subsequent workup revealed an underlying uterine sarcoma.
Findings:
- The patient underwent surgical removal of the uterine sarcoma followed by chemotherapy (carboplatin and cyclophosphamide).
- Post-treatment, the patient experienced significant visual improvement and stabilization of her visual fields.
- This case establishes a direct link between uterine sarcoma and cancer-associated retinopathy.
Implications:
- This case highlights the importance of considering paraneoplastic syndromes, including CAR, in patients with unexplained visual disturbances.
- Early diagnosis and treatment of the underlying malignancy are crucial for managing CAR and improving visual outcomes.
- Further research into the mechanisms of paraneoplastic retinopathy in gynecologic cancers is warranted.